Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Diurnal Ltd.
DescriptionCombination therapy of the thyroid hormones T3 (triiodothyronine) and T4 (thyroxine)
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationThyroid disease
Indication DetailsTreat hyperthyroidism
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today